TABLE 3.
B-cell variable | Clinical variable | Independent variables per model | q-value of clinical variable | |||
Term | Estimate | se | p-value | |||
CD27+IgA+ memory B-cells | AX | AX | 0.886 | 0.167 | <0.001 | <0.001 |
Age | 0.034 | 0.016 | 0.039 | |||
Regular OCS | 2.001 | 0.624 | 0.002 | |||
(Intercept) | 1.358 | 0.869 | ||||
CD27+IgA+ memory B-cells | R5−R20 | R5−R20 | 9.117 | 2.240 | <0.001 | 0.002 |
Age | 0.031 | 0.017 | 0.066 | |||
Regular OCS | 2.156 | 0.627 | 0.001 | |||
(Intercept) | 1.307 | 0.896 | ||||
CD27+IgA+ memory B-cells | FEF25–75% (z-score) | FEF25–75% (z-score) | −0.683 | 0.225 | 0.003 | 0.026 |
Age | 0.046 | 0.019 | 0.020 | |||
Regular OCS | 2.154 | 0.713 | 0.003 | |||
(Intercept) | 0.764 | 1.097 | ||||
CD27+IgA+ memory B-cells | FEV1 (z-score) | FEV1 (z-score) | −0.541 | 0.177 | 0.003 | 0.026 |
Age | 0.049 | 0.017 | 0.005 | |||
Regular OCS | 2.137 | 0.663 | 0.002 | |||
(Intercept) | 0.902 | 0.940 | ||||
CD27+IgA+ memory B-cells | FEV1/FVC (z-score) | FEV1/FVC (z-score) | −0.597 | 0.192 | 0.002 | 0.026 |
Age | 0.044 | 0.017 | 0.010 | |||
Regular OCS | 2.279 | 0.649 | 0.001 | |||
(Intercept) | 0.815 | 0.944 | ||||
CD27−IgA+ memory B-cells | Number of severe exacerbations | Number of severe exacerbations | 0.223 | 0.068 | 0.001 | 0.026 |
Age | 0.0003 | 0.011 | 0.975 | |||
Regular OCS | 0.613 | 0.475 | 0.199 | |||
(Intercept) | 2.097 | 0.591 | ||||
CD27−IgA+ memory B-cells | AX | AX | 0.339 | 0.111 | 0.003 | 0.026 |
Age | −0.003 | 0.011 | 0.803 | |||
Regular OCS | 0.997 | 0.415 | 0.017 | |||
(Intercept) | 2.173 | 0.578 | ||||
CD27−IgA+ memory B-cells | R5−R20 | R5−R20 | 4.224 | 1.448 | 0.004 | 0.032 |
Age | −0.004 | 0.011 | 0.718 | |||
Regular OCS | 1.152 | 0.406 | 0.005 | |||
(Intercept) | 2.084 | 0.579 |
Linear model describing B-cell subpopulations as a function of clinical characteristics with oral corticosteroids (OCS) and age as confounders. Coefficient estimate, standard error and p-value are given for each term in the model. p-values for the clinical variables were corrected for multiple tests (q-value) and all significant results are shown (q<0.05). AX: reactance area; R5–R20: resistance at 5 Hz−resistance at 20 Hz; FEF25–75%: forced expiratory flow at 25–75% of FVC; FEV1: forced expiratory volume in 1 s; FVC: forced vital capacity.